Ryan M. Imrie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ryan M. Imrie has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Ben Longdon
University of Exeter
11 shared publications - Sarah K. Walsh
MRC-University of Glasgow Centre for Virus Research, Glasgow, UK
6 shared publications - Megan Anne Wallace
Centre for Ecology and Conservation, Faculty of Environment, Science and Economy, University of Exeter
4 shared publications - Angus Buckling
University of Exeter
3 shared publications Ben Longdon
Centre for Ecology & Conservation, Faculty of Environment, Science, and Economy, University of Exeter, Penryn Campus , Penryn
3 shared publications- Katherine E. Roberts
Biology and Evolution of Marine Organisms (BEOM), Stazione Zoologica Anton Dhorn, Naples, Italy
3 shared publications
Latest Publications
- Open Access
- 10 June 2026
- Published by Elsevier in SSRN Electronic Journal
Rapid Modelling of the 2026 Andes Virus Outbreak Predicts Limited Transmissibility and Low Mainland Outbreak Risk
Background: In May 2026, an outbreak of Andes virus (ANDV) infection was reported among passengers and crew of the cruise ship MV Hondius. As of 27 May, 13 linked cases and three deaths had been reported, with ongoing concern about onward transmission after disembarkation. Methods: We conducted a responsive analysis of the ongoing outbreak using publicly available data published by international public health bodies. We reconstructed plausible transmission chains and fitted a stochastic agent-based model of onboard transmission to estimate the probability of transmission per close contact. We then extrapolated the inferred per-contact transmissibility to mainland UK contact rates and simulated potential mainland outbreaks using a stochastic hybrid agent-compartment model. Findings: The model identified a pattern of early transmission heterogeneity consistent with superspreading aboard the ship. After accounting for this heterogeneity, estimated per-contact transmissibility was low, with a median value of 0.006 (95% interval: 0.001–0.019). This corresponded to an onboard R0, defined as the expected number of infections caused by an average infected person aboard the ship, of 0.36 (95% interval: 0.11–1.24). Extrapolating to mainland UK contact rates gave a mainland R0 of 0.19 (95% interval: 0.06–0.67), below the (R=1) threshold required for sustained transmission. Interpretation: Continued control measures remain appropriate given the severity of ANDV infection, and our results do not exclude onward viral transmission if containment measures fail. However, the inferred transmissibility of ANDV in this outbreak suggests that the risk of a sustained or sizeable mainland outbreak is low.
- 10 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessRapid Modelling of the 2026 Andes Virus Outbreak Predicts Limited Transmissibility and Low Mainland Outbreak Risk
Background: In May 2026, an outbreak of Andes virus (ANDV) infection was reported among passengers and crew of the cruise ship MV Hondius. As of 27 May, 13 linked cases and three deaths had been reported, with ongoing concern about onward transmission after disembarkation. Methods: We conducted a responsive analysis of the ongoing outbreak using publicly available data published by international public health bodies. We reconstructed plausible transmission chains and fitted a stochastic agent-based model of onboard transmission to estimate the probability of transmission per close contact. We then extrapolated the inferred per-contact transmissibility to mainland UK contact rates and simulated potential mainland outbreaks using a stochastic hybrid agent-compartment model. Findings: The model identified a pattern of early transmission heterogeneity consistent with superspreading aboard the ship. After accounting for this heterogeneity, estimated per-contact transmissibility was low, with a median value of 0.006 (95% interval: 0.001–0.019). This corresponded to an onboard R0, defined as the expected number of infections caused by an average infected person aboard the ship, of 0.36 (95% interval: 0.11–1.24). Extrapolating to mainland UK contact rates gave a mainland R0 of 0.19 (95% interval: 0.06–0.67), below the (R=1) threshold required for sustained transmission. Interpretation: Continued control measures remain appropriate given the severity of ANDV infection, and our results do not exclude onward viral transmission if containment measures fail. However, the inferred transmissibility of ANDV in this outbreak suggests that the risk of a sustained or sizeable mainland outbreak is low.
- Open Access
Examining interactions between the microbiome and viral infection across Drosophila species
Microbiomes can influence the outcomes of virus infection, while viral infections can disrupt microbiome composition. These reciprocal interactions may contribute to patterns of host susceptibility, but it remains unclear whether microbiome-virus interactions are consistent across host species, or whether host evolutionary relationships influence microbiome variation and its association with viral susceptibility. Here, we investigate interactions between bacterial microbiomes and Drosophila C virus (DCV) infection across 32 Drosophilidae host species, using experimental infections and 16S rRNA amplicon sequencing. Using phylogenetic mixed models, we tested for phylogenetic structure in microbiome diversity and composition, and whether specific bacterial taxa were associated with among-species variation in viral load. Drosophilidae microbiomes were consistently dominated by a small number of bacterial genera and showed limited phylogenetic structuring. DCV infection was associated with a small reduction in bacterial richness, but microbiome composition was only weakly affected by wounding or infection and largely dominated by within-species variation. However, specific taxa were associated with large differences in viral replication, including reduced DCV load in flies harbouring Streptococcus before infection or Bacillus during infection. These results suggest that, at least in the conditions used in this study, microbiome composition may not generate strong, generalisable host phylogenetic patterns in virus susceptibility.
Open AccessExamining interactions between the microbiome and viral infection across Drosophila species
Microbiomes can influence the outcomes of virus infection, while viral infections can disrupt microbiome composition. These reciprocal interactions may contribute to patterns of host susceptibility, but it remains unclear whether microbiome-virus interactions are consistent across host species, or whether host evolutionary relationships influence microbiome variation and its association with viral susceptibility. Here, we investigate interactions between bacterial microbiomes and Drosophila C virus (DCV) infection across 32 Drosophilidae host species, using experimental infections and 16S rRNA amplicon sequencing. Using phylogenetic mixed models, we tested for phylogenetic structure in microbiome diversity and composition, and whether specific bacterial taxa were associated with among-species variation in viral load. Drosophilidae microbiomes were consistently dominated by a small number of bacterial genera and showed limited phylogenetic structuring. DCV infection was associated with a small reduction in bacterial richness, but microbiome composition was only weakly affected by wounding or infection and largely dominated by within-species variation. However, specific taxa were associated with large differences in viral replication, including reduced DCV load in flies harbouring Streptococcus before infection or Bacillus during infection. These results suggest that, at least in the conditions used in this study, microbiome composition may not generate strong, generalisable host phylogenetic patterns in virus susceptibility.
- Open Access
- 24 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 2248
Post-pandemic changes in population immunity have reduced the likelihood of emergence of zoonotic coronaviruses
Infections by endemic viruses, and the vaccines used to control them, often provide cross-protection against related viruses, potentially altering the transmission dynamics and likelihood of emergence of new zoonotic viruses with pandemic potential. Here, we investigate how population immunity after the COVID-19 pandemic has impacted the likelihood of emergence of a novel sarbecovirus, termed SARS-CoV-X. To this end, we combined empirical cross-neutralisation data with mathematical modelling to identify key immunological and epidemiological factors shaping sarbecovirus emergence. We show that sera from individuals with different COVID-19 immunological histories contained cross-neutralising antibodies against the spike (S) protein of multiple zoonotic sarbecoviruses. Simulations parameterised by these data predict that the likelihood of emergence of a novel sarbecovirus has been reduced significantly by population cross-immunity, with outcomes determined by the extent of cross-protection and R0 of the novel virus. Preventative vaccination against SARS-CoV-X using available COVID-19 vaccines can help resist emergence even in the presence of co-circulating SARS-CoV-2. However, a theoretical vaccine with high specificity to SARS-CoV-2 can increase emergence probability by suppressing SARS-CoV-2 prevalence and, by extension, levels of natural cross-protection. Overall, SARS-CoV-2 circulation and vaccination have generated widespread immunity against related sarbecoviruses, creating an immunological barrier to novel sarbecovirus emergence in humans.
- 24 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 2248
Open AccessPost-pandemic changes in population immunity have reduced the likelihood of emergence of zoonotic coronaviruses
Infections by endemic viruses, and the vaccines used to control them, often provide cross-protection against related viruses, potentially altering the transmission dynamics and likelihood of emergence of new zoonotic viruses with pandemic potential. Here, we investigate how population immunity after the COVID-19 pandemic has impacted the likelihood of emergence of a novel sarbecovirus, termed SARS-CoV-X. To this end, we combined empirical cross-neutralisation data with mathematical modelling to identify key immunological and epidemiological factors shaping sarbecovirus emergence. We show that sera from individuals with different COVID-19 immunological histories contained cross-neutralising antibodies against the spike (S) protein of multiple zoonotic sarbecoviruses. Simulations parameterised by these data predict that the likelihood of emergence of a novel sarbecovirus has been reduced significantly by population cross-immunity, with outcomes determined by the extent of cross-protection and R0 of the novel virus. Preventative vaccination against SARS-CoV-X using available COVID-19 vaccines can help resist emergence even in the presence of co-circulating SARS-CoV-2. However, a theoretical vaccine with high specificity to SARS-CoV-2 can increase emergence probability by suppressing SARS-CoV-2 prevalence and, by extension, levels of natural cross-protection. Overall, SARS-CoV-2 circulation and vaccination have generated widespread immunity against related sarbecoviruses, creating an immunological barrier to novel sarbecovirus emergence in humans.
- Open Access
Bacterial phylogeny explains variation in virulence but not phage efficacy in vivo
The continuing emergence of antimicrobial resistance (AMR) poses one of the most urgent threats to public health in the 21 st century, causing ∼1.2 million deaths per year. A promising alternative to traditional antimicrobials is phage therapy, which has proved effective in the treatment of antimicrobial-resistant infections, including methicillin-resistant Staphylococcus aureus (MRSA). However, considerable variation in the outcome of phage therapy remains, with phage that show high efficacy in vitro often showing little to no effect when applied in vivo. To allow for the efficient clinical use of phage, it is vital to understand how both bacterial virulence and phage efficacy vary in vivo and determine how well in vitro and in vivo measures of phage efficacy correlate. Here, we infected 4,968 Galleria mellonella larvae with 64 phylogenetically diverse Staphylococcaceae isolates, both with and without co-inoculation of the bacteriophage ISP, and recorded mortality and melanisation over 24 hours. We found that bacterial virulence varied among Staphylococcaceae strains, and that a large proportion of this variation could be explained by the evolutionary relationships between bacteria. These results indicate that pathogen phylogeny may be a useful tool for explaining variation in both the severity of clinical infections and the virulence of novel emerging pathogens. The addition of phage significantly improved the survival of G. mellonella larvae, with an average 15.2% increase in endpoint survival and 10.1% reduction in endpoint melanisation across Staphylococcaceae strains. Phage efficacy in vivo showed phylogenetic repeatability, but no detectable phylogenetic heritability across bacteria species, in contrast to previous in vitro studies of phage infections. Concurrently, we found no evidence of a correlation between in vivo and in vitro measures of phage efficacy across bacterial isolates, demonstrating that environment plays a major role in determining the outcomes of bacteria-phage interactions. This highlights that caution should be used when extrapolating from in vitro measures of phage efficacy to select phages for therapeutic uses.
Open AccessBacterial phylogeny explains variation in virulence but not phage efficacy in vivo
The continuing emergence of antimicrobial resistance (AMR) poses one of the most urgent threats to public health in the 21 st century, causing ∼1.2 million deaths per year. A promising alternative to traditional antimicrobials is phage therapy, which has proved effective in the treatment of antimicrobial-resistant infections, including methicillin-resistant Staphylococcus aureus (MRSA). However, considerable variation in the outcome of phage therapy remains, with phage that show high efficacy in vitro often showing little to no effect when applied in vivo. To allow for the efficient clinical use of phage, it is vital to understand how both bacterial virulence and phage efficacy vary in vivo and determine how well in vitro and in vivo measures of phage efficacy correlate. Here, we infected 4,968 Galleria mellonella larvae with 64 phylogenetically diverse Staphylococcaceae isolates, both with and without co-inoculation of the bacteriophage ISP, and recorded mortality and melanisation over 24 hours. We found that bacterial virulence varied among Staphylococcaceae strains, and that a large proportion of this variation could be explained by the evolutionary relationships between bacteria. These results indicate that pathogen phylogeny may be a useful tool for explaining variation in both the severity of clinical infections and the virulence of novel emerging pathogens. The addition of phage significantly improved the survival of G. mellonella larvae, with an average 15.2% increase in endpoint survival and 10.1% reduction in endpoint melanisation across Staphylococcaceae strains. Phage efficacy in vivo showed phylogenetic repeatability, but no detectable phylogenetic heritability across bacteria species, in contrast to previous in vitro studies of phage infections. Concurrently, we found no evidence of a correlation between in vivo and in vitro measures of phage efficacy across bacterial isolates, demonstrating that environment plays a major role in determining the outcomes of bacteria-phage interactions. This highlights that caution should be used when extrapolating from in vitro measures of phage efficacy to select phages for therapeutic uses.
- Open Access
- 14 January 2026
- Published by Oxford University Press (OUP) in ISME Communications
- Vol. 6 (1)
Detectable effects of bacterial phylogeny on virulence but not phage efficacy in an in vivo Galleria mellonella model
Predicting the outcomes of bacteria–phage interactions is a central challenge in microbial ecology, particularly across heterogeneous host environments. Evolutionary relatedness among bacteria can explain variation in phage susceptibility in vitro, but it remains unclear whether this predictive relationship persists in complex host environments and to what extent relatedness also explains variation in other bacterial traits, such as virulence. Here, we used an in vivo infection model to quantify how bacterial phylogeny and host environmental context mediate bacterial virulence and bacteria–phage interactions. We infected 4,608 Galleria mellonella larvae with 64 phylogenetically diverse Staphylococcaceae isolates, both with and without co-inoculation of the bacteriophage ISP, and recorded mortality and melanisation over 24 hours. We found that bacterial virulence varied among Staphylococcaceae strains and that a large proportion of this variation could be explained by the evolutionary relationships between bacteria, indicating that phylogeny may be useful in predicting bacterial virulence. The addition of phage significantly improved the survival of G. mellonella larvae, with an average 15.2% increase in endpoint survival and 10.1% reduction in endpoint melanisation across Staphylococcaceae strains. Unlike previous in vitro studies, the evolutionary relationships between bacterial isolates could not explain variation in in vivo phage efficacy across Staphylococcaceae. Concurrently, we found no evidence of a correlation between in vivo and in vitro measures of phage efficacy across bacterial isolates, highlighting the importance of the host environment in shaping bacteria–phage dynamics.
- 14 January 2026
- Published by Oxford University Press (OUP) in ISME Communications
- Vol. 6 (1)
Open AccessDetectable effects of bacterial phylogeny on virulence but not phage efficacy in an in vivo Galleria mellonella model
Predicting the outcomes of bacteria–phage interactions is a central challenge in microbial ecology, particularly across heterogeneous host environments. Evolutionary relatedness among bacteria can explain variation in phage susceptibility in vitro, but it remains unclear whether this predictive relationship persists in complex host environments and to what extent relatedness also explains variation in other bacterial traits, such as virulence. Here, we used an in vivo infection model to quantify how bacterial phylogeny and host environmental context mediate bacterial virulence and bacteria–phage interactions. We infected 4,608 Galleria mellonella larvae with 64 phylogenetically diverse Staphylococcaceae isolates, both with and without co-inoculation of the bacteriophage ISP, and recorded mortality and melanisation over 24 hours. We found that bacterial virulence varied among Staphylococcaceae strains and that a large proportion of this variation could be explained by the evolutionary relationships between bacteria, indicating that phylogeny may be useful in predicting bacterial virulence. The addition of phage significantly improved the survival of G. mellonella larvae, with an average 15.2% increase in endpoint survival and 10.1% reduction in endpoint melanisation across Staphylococcaceae strains. Unlike previous in vitro studies, the evolutionary relationships between bacterial isolates could not explain variation in in vivo phage efficacy across Staphylococcaceae. Concurrently, we found no evidence of a correlation between in vivo and in vitro measures of phage efficacy across bacterial isolates, highlighting the importance of the host environment in shaping bacteria–phage dynamics.
- Open Access
- 16 April 2025
- Published by The Royal Society in Proceedings Of The Royal Society B-Biological Sciences
- Vol. 292 (2045) , 20242239
Varying phylogenetic signal in susceptibility to four bacterial pathogens across species of Drosophilidae
Bacterial infections are a major threat to public health. Pathogen host shifts—where a pathogen jumps from one host species to another—are important sources of emerging infectious diseases. However, compared with viruses, we know relatively little about the factors that determine whether bacteria can infect a novel host, such as how host phylogenetics constrains variation in pathogen host range and the link between host phylogeny and the infectivity and virulence of a pathogen. Here, we experimentally examined susceptibility to bacterial infections using a panel of 36 Drosophilidae species and four pathogens ( Providencia rettgeri , Pseudomonas entomophila , Enterococcus faecalis , Staphylococcus aureus ). The outcomes of infection differed greatly among pathogens and across host species. The host phylogeny explains a considerable amount of variation in susceptibility, with the greatest phylogenetic signal for P. rettgeri infection, explaining 94% of the variation in mortality. Positive correlations were observed between mortality and bacterial load for three out of the four pathogens. Correlations in susceptibility between the four pathogens were positive but largely non-significant, suggesting susceptibility is mostly pathogen-specific. These results suggest that susceptibility to bacterial pathogens may be predicted by the host phylogeny, but the effect may vary in magnitude between different bacteria.
- 16 April 2025
- Published by The Royal Society in Proceedings Of The Royal Society B-Biological Sciences
- Vol. 292 (2045) , 20242239
Open AccessVarying phylogenetic signal in susceptibility to four bacterial pathogens across species of Drosophilidae
Bacterial infections are a major threat to public health. Pathogen host shifts—where a pathogen jumps from one host species to another—are important sources of emerging infectious diseases. However, compared with viruses, we know relatively little about the factors that determine whether bacteria can infect a novel host, such as how host phylogenetics constrains variation in pathogen host range and the link between host phylogeny and the infectivity and virulence of a pathogen. Here, we experimentally examined susceptibility to bacterial infections using a panel of 36 Drosophilidae species and four pathogens ( Providencia rettgeri , Pseudomonas entomophila , Enterococcus faecalis , Staphylococcus aureus ). The outcomes of infection differed greatly among pathogens and across host species. The host phylogeny explains a considerable amount of variation in susceptibility, with the greatest phylogenetic signal for P. rettgeri infection, explaining 94% of the variation in mortality. Positive correlations were observed between mortality and bacterial load for three out of the four pathogens. Correlations in susceptibility between the four pathogens were positive but largely non-significant, suggesting susceptibility is mostly pathogen-specific. These results suggest that susceptibility to bacterial pathogens may be predicted by the host phylogeny, but the effect may vary in magnitude between different bacteria.
- Open Access
- 2 April 2025
- Published by The Royal Society in Proceedings Of The Royal Society B-Biological Sciences
- Vol. 292 (2044) , 20250389
Making sense of the virome in light of evolution and ecology
Understanding the patterns and drivers of viral prevalence and abundance is of key importance for understanding pathogen emergence. Over the last decade, metagenomic sequencing has exponentially expanded our knowledge of the diversity and evolution of viruses associated with all domains of life. However, as most of these ‘virome’ studies are primarily descriptive, our understanding of the predictors of virus prevalence, abundance and diversity, and their variation in space and time, remains limited. For example, we do not yet understand the relative importance of ecological predictors (e.g. seasonality and habitat) versus evolutionary predictors (e.g. host and virus phylogenies) in driving virus prevalence and diversity. Few studies are set up to reveal the factors that predict the virome composition of individual hosts, populations or species. In addition, most studies of virus ecology represent a snapshot of single species viromes at a single point in time and space. Fortunately, recent studies have begun to use metagenomic data to directly test hypotheses about the evolutionary and ecological factors which drive virus prevalence, sharing and diversity. By synthesizing evidence across studies, we present some over-arching ecological and evolutionary patterns in virome composition, and illustrate the need for additional work to quantify the drivers of virus prevalence and diversity.
- 2 April 2025
- Published by The Royal Society in Proceedings Of The Royal Society B-Biological Sciences
- Vol. 292 (2044) , 20250389
Open AccessMaking sense of the virome in light of evolution and ecology
Understanding the patterns and drivers of viral prevalence and abundance is of key importance for understanding pathogen emergence. Over the last decade, metagenomic sequencing has exponentially expanded our knowledge of the diversity and evolution of viruses associated with all domains of life. However, as most of these ‘virome’ studies are primarily descriptive, our understanding of the predictors of virus prevalence, abundance and diversity, and their variation in space and time, remains limited. For example, we do not yet understand the relative importance of ecological predictors (e.g. seasonality and habitat) versus evolutionary predictors (e.g. host and virus phylogenies) in driving virus prevalence and diversity. Few studies are set up to reveal the factors that predict the virome composition of individual hosts, populations or species. In addition, most studies of virus ecology represent a snapshot of single species viromes at a single point in time and space. Fortunately, recent studies have begun to use metagenomic data to directly test hypotheses about the evolutionary and ecological factors which drive virus prevalence, sharing and diversity. By synthesizing evidence across studies, we present some over-arching ecological and evolutionary patterns in virome composition, and illustrate the need for additional work to quantify the drivers of virus prevalence and diversity.
- Open Access
Post-pandemic changes in population immunity have reduced the likelihood of emergence of zoonotic coronaviruses
Infections caused by endemic viruses, and the vaccines used to control them, often provide cross-protection against related viruses. This cross-protection has the potential to alter the transmission dynamics and likelihood of emergence of novel zoonotic viruses with pandemic potential. Here, we investigate how changes in population immunity after the COVID-19 pandemic have impacted the likelihood of emergence of a novel sarbecovirus, termed SARS-CoV-X. We show that sera from patients with different COVID-19 immunological histories possess cross-neutralising antibodies against the spike (S) protein of multiple zoonotic sarbecoviruses. Mathematical simulations using these viruses show a significant reduction in their likelihood of emergence in populations with current levels of SARS-CoV-2 natural and vaccine-derived immunity, with the outcome determined by the extent of cross-protection and the R 0 of the novel virus. We also show that preventative vaccination programs against SARS-CoV-X using currently available COVID-19 vaccines can help resist emergence even in the presence of co-circulating SARS-CoV-2. However, it was possible for a theoretical vaccine with very high specificity to SARS-CoV-2 (i.e., one which elicits very low cross-protection against SARS-CoV-X) to increase the likelihood of SARS-CoV-X emergence, due to its effects on SARS-CoV-2 prevalence and, by extension, the levels of naturally-derived cross-protection in the human population. Overall, our findings show that SARS-CoV-2 circulation and COVID-19 vaccination have generated widespread population immunity against antigenically related sarbecoviruses, and this new immunological barrier is likely to be a strong determinant of the ability of novel sarbecoviruses to emerge in humans. One-Sentence Summary: Future emergence of zoonotic coronaviruses is less likely due to post-pandemic shifts in population immunity.
Open AccessPost-pandemic changes in population immunity have reduced the likelihood of emergence of zoonotic coronaviruses
Infections caused by endemic viruses, and the vaccines used to control them, often provide cross-protection against related viruses. This cross-protection has the potential to alter the transmission dynamics and likelihood of emergence of novel zoonotic viruses with pandemic potential. Here, we investigate how changes in population immunity after the COVID-19 pandemic have impacted the likelihood of emergence of a novel sarbecovirus, termed SARS-CoV-X. We show that sera from patients with different COVID-19 immunological histories possess cross-neutralising antibodies against the spike (S) protein of multiple zoonotic sarbecoviruses. Mathematical simulations using these viruses show a significant reduction in their likelihood of emergence in populations with current levels of SARS-CoV-2 natural and vaccine-derived immunity, with the outcome determined by the extent of cross-protection and the R 0 of the novel virus. We also show that preventative vaccination programs against SARS-CoV-X using currently available COVID-19 vaccines can help resist emergence even in the presence of co-circulating SARS-CoV-2. However, it was possible for a theoretical vaccine with very high specificity to SARS-CoV-2 (i.e., one which elicits very low cross-protection against SARS-CoV-X) to increase the likelihood of SARS-CoV-X emergence, due to its effects on SARS-CoV-2 prevalence and, by extension, the levels of naturally-derived cross-protection in the human population. Overall, our findings show that SARS-CoV-2 circulation and COVID-19 vaccination have generated widespread population immunity against antigenically related sarbecoviruses, and this new immunological barrier is likely to be a strong determinant of the ability of novel sarbecoviruses to emerge in humans. One-Sentence Summary: Future emergence of zoonotic coronaviruses is less likely due to post-pandemic shifts in population immunity.
- Open Access
- 5 February 2025
- Published by Oxford University Press (OUP) in Evolution Letters
- Vol. 9 (3) , 335-345
Positive correlations in susceptibility to a diverse panel of viruses across Drosophilidae host species
Our ability to predict the emergence of novel viruses relies on there being generalizable patterns in the susceptibilities of hosts to novel infections. Studies investigating variation in susceptibility among host species have consistently shown that closely related hosts share similar susceptibilities to a given virus. However, the extent to which such phylogenetic patterns of susceptibility are correlated among diverse sets of viruses is unclear. Here, we investigate phylogenetic correlations in susceptibility among Drosophilidae hosts to a panel of 11 different invertebrate viruses, comprising 7 unique virus species, 6 unique families, and both RNA and DNA viruses. The susceptibility of hosts to each pair of viruses tested was either positively correlated across host species or did not show evidence of correlation. No negative correlations, indicative of evolutionary trade-offs in host susceptibility to different viruses, were detected between any virus pairs. The strength of correlations was generally higher in viruses of the same species and family, consistent with virus phylogenetic patterns in host infectivity. Our results suggest that generalized host susceptibility can result in positive correlations, even between highly diverged viruses, while specialized interactions with individual viruses cause a stepwise decrease in correlation strength between viruses from the within-species, to the within-family, and to the across-family level.
- 5 February 2025
- Published by Oxford University Press (OUP) in Evolution Letters
- Vol. 9 (3) , 335-345
Open AccessPositive correlations in susceptibility to a diverse panel of viruses across Drosophilidae host species
Our ability to predict the emergence of novel viruses relies on there being generalizable patterns in the susceptibilities of hosts to novel infections. Studies investigating variation in susceptibility among host species have consistently shown that closely related hosts share similar susceptibilities to a given virus. However, the extent to which such phylogenetic patterns of susceptibility are correlated among diverse sets of viruses is unclear. Here, we investigate phylogenetic correlations in susceptibility among Drosophilidae hosts to a panel of 11 different invertebrate viruses, comprising 7 unique virus species, 6 unique families, and both RNA and DNA viruses. The susceptibility of hosts to each pair of viruses tested was either positively correlated across host species or did not show evidence of correlation. No negative correlations, indicative of evolutionary trade-offs in host susceptibility to different viruses, were detected between any virus pairs. The strength of correlations was generally higher in viruses of the same species and family, consistent with virus phylogenetic patterns in host infectivity. Our results suggest that generalized host susceptibility can result in positive correlations, even between highly diverged viruses, while specialized interactions with individual viruses cause a stepwise decrease in correlation strength between viruses from the within-species, to the within-family, and to the across-family level.
- Open Access
Positive correlations in susceptibility to a diverse panel of viruses across host species
Our ability to predict the emergence of novel viruses relies on there being generalisable patterns in the susceptibilities of hosts to novel infections. Studies investigating variation in susceptibility among host species have consistently shown that closely related hosts share similar susceptibilities to a given virus. However, the extent to which such phylogenetic patterns of susceptibility are correlated amongst diverse sets of viruses is unclear. Here, we investigate phylogenetic correlations in susceptibility among Drosophilidae hosts to a panel of eleven different invertebrate viruses, comprising seven unique virus species, six unique families, and both RNA and DNA viruses. The susceptibility of hosts to each pair of viruses tested was either positively correlated across host species or did not show evidence of correlation. No negative correlations, indicative of evolutionary trade-offs in host susceptibility to different viruses, were detected between any virus pairs. The strength of correlations were generally higher in viruses of the same species and family, consistent with virus phylogenetic patterns in host infectivity. Our results suggest that generalised host susceptibility can result in positive correlations, even between highly diverged viruses, while specialised interactions with individual viruses cause a stepwise decrease in correlation strength between viruses from the within-species, to the within-family, to the across-family level.
Open AccessPositive correlations in susceptibility to a diverse panel of viruses across host species
Our ability to predict the emergence of novel viruses relies on there being generalisable patterns in the susceptibilities of hosts to novel infections. Studies investigating variation in susceptibility among host species have consistently shown that closely related hosts share similar susceptibilities to a given virus. However, the extent to which such phylogenetic patterns of susceptibility are correlated amongst diverse sets of viruses is unclear. Here, we investigate phylogenetic correlations in susceptibility among Drosophilidae hosts to a panel of eleven different invertebrate viruses, comprising seven unique virus species, six unique families, and both RNA and DNA viruses. The susceptibility of hosts to each pair of viruses tested was either positively correlated across host species or did not show evidence of correlation. No negative correlations, indicative of evolutionary trade-offs in host susceptibility to different viruses, were detected between any virus pairs. The strength of correlations were generally higher in viruses of the same species and family, consistent with virus phylogenetic patterns in host infectivity. Our results suggest that generalised host susceptibility can result in positive correlations, even between highly diverged viruses, while specialised interactions with individual viruses cause a stepwise decrease in correlation strength between viruses from the within-species, to the within-family, to the across-family level.